Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Findings of Research Misconduct.

Federal register·2026
Same journal

Findings of Research Misconduct.

Federal register·2026
Same journal

Findings of Research Misconduct.

Federal register·2026
Same journal

Findings of Research Misconduct.

Federal register·2025
Same journal

Findings of Research Misconduct.

Federal register·2025
Same journal

Findings of Research Misconduct.

Federal register·2024

Related Experiment Video

Updated: May 9, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Organ procurement and transplantation network. Final rule.

    Federal Register
    |July 10, 2013
    PubMed
    Summary

    The Department of Health and Human Services (HHS) now includes vascularized composite allografts (VCAs) in the definition of organs regulated by the Organ Procurement and Transplantation Network (OPTN). This regulatory update expands the scope of organ transplantation eligibility and oversight.

    Area of Science:

    • Transplantation Medicine
    • Regulatory Affairs
    • Medical Policy

    Background:

    • The National Organ Transplant Act (NOTA) of 1984 defined 'organ' and allowed for regulatory expansion.
    • Previous definitions by the Secretary of HHS covered specific solid organs and associated blood vessels for transplantation.
    • Vascularized composite allografts (VCAs) were not explicitly included in the prior definition of covered organs.

    Purpose of the Study:

    • To update the definition of organs covered under the Organ Procurement and Transplantation Network (OPTN) final rule.
    • To formally include vascularized composite allografts (VCAs) within the regulatory framework for organ transplantation.
    • To align the OPTN definition of organs with the broader scope intended by NOTA.

    Main Methods:

    More Related Videos

    Study of Experimental Organ Donation Models for Lung Transplantation
    08:56

    Study of Experimental Organ Donation Models for Lung Transplantation

    Published on: March 15, 2024

    Related Experiment Videos

    Last Updated: May 9, 2026

    Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
    09:54

    Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

    Published on: August 15, 2022

    Study of Experimental Organ Donation Models for Lung Transplantation
    08:56

    Study of Experimental Organ Donation Models for Lung Transplantation

    Published on: March 15, 2024

  • Issuance of a final rule by the Department of Health and Human Services (HHS).
  • Amendment of the definition of 'organ' as used in the OPTN final rule.
  • Inclusion of specific vascularized composite allografts (VCAs) in the updated definition.

    • Main Results:

    • Vascularized composite allografts (VCAs) are now officially included in the definition of organs covered by the OPTN.
    • The regulatory definition of human organs under NOTA has been correspondingly updated.
    • This expansion clarifies the eligibility and oversight for VCAs in organ transplantation.

    Conclusions:

    • The final rule expands the scope of the OPTN to encompass VCAs.
    • This regulatory change supports the broader application of organ transplantation principles to VCAs.
    • HHS has successfully utilized its authority to update the definition of organs under NOTA.